Neutral
argenx (Euronext & Nasdaq: ARGX) announced it will host a conference call and audio webcast on Thursday, May 7, 2026, at 2:30 PM CET (8:30 AM ET) to d...
Neutral
argenx (Euronext & Nasdaq: ARGX) announced it will host a conference call and audio webcast on May 7, 2026, at 2:30 PM CET / 8:30 AM ET to discuss its...
Bullish
This article analyzes Argenx SE's (NL0010832176) prospects, focusing on its immunology drug Vyvgart and its potential to expand into new autoimmune di...